Skip to main content
DrugPrice

Bristol-Myers Squibb — Drug Prices & Medicare Spending

Bristol-Myers Squibb manufactures 20 drugs tracked by Medicare Part D with total spending of $39.5B.

20
Drugs Tracked
$39.5B
Medicare Spending
$758.43
Avg Cost/Claim
90%
Have Generics

Bristol-Myers Squibb Drugs — Ranked by Medicare Spending

#DrugGeneric NameCost/ClaimGeneric?
1EliquisApixaban$510.00Yes
2RevlimidLenalidomide$12,786.00No
3OpdivoNivolumab$15,821.00Yes
4PomalystPomalidomide$17,250.00No
5OrenciaAbatacept$3,546.00Yes
6YervoyIpilimumab$13,058.00Yes
7SprycelDasatinib$7,065.00Yes
8ReblozylLuspatercept$6,593.00Yes
9OpdualagNivolumab/Relatlimab$13,500.00Yes
10ZeposiaOzanimod$6,706.00Yes
11VidazaAzacitidine$9,583.00Yes
12ThalomidThalidomide$13,000.00Yes
13InrebicFedratinib$16,714.00Yes
14SotyktuDeucravacitinib$3,441.00Yes
15NulojixBelatacept$2,721.00Yes
16BaracludeEntecavir$1,435.00Yes
17PravastatinPravastatin Sodium$10.00Yes
18WarfarinWarfarin Sodium$10.00Yes
19IdhifaEnasidenib$14,833.00Yes
20SustivaEfavirenz$1,854.00Yes

Frequently Asked Questions

Bristol-Myers Squibb manufactures 20 drugs tracked by Medicare Part D, with total annual spending of $39.5B.

Pomalyst (Pomalidomide) is the most expensive at $17,250.00 per claim.

18 of 20 Bristol-Myers Squibb drugs (90%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.